Skip to content
Medical Health Aged Care

RACGP urges RSV immunisation rollout to keep vulnerable Victorian infants safe

Royal Australian College of GPs 2 mins read

The Royal Australian College of GPs (RACGP) has called on the Victorian Government to follow other states’ lead and commit to rolling out an RSV immunisation program that will save lives.

Respiratory syncytial virus, or RSV, is common respiratory infection which mostly affects young children, including babies. The symptoms are usually mild and manageable at home; however, some children and adults can become extremely ill and require hospital treatment. There were more than 128,000 cases reported last year Australia-wide, causing symptoms that ranged from mild to life-threatening.

The Federal Department of Health and Aged Care’s disease surveillance tool shows cases in Victoria have increased from 3,400 cases in the first quarter of 2024 to 8,584 cases in the current, second quarter, surpassing Queensland in May.

More than half of all RSV cases are among infants and children under five. Research has found RSV is likely the most common reason for hospital presentation among infants aged 12 months or younger, and there has been a steady growth in global RSV hospitalisations since 2009.

Immunisation is available however, and clinical trials indicate an injectable antibody can reduce hospitalisations by 83%. Previously, the College welcomed action to tackle RSV through infant immunisation in Western Australia, New South Wales, and Queensland.

RACGP Victoria Chair Dr Anita Muñoz said immunisations for vulnerable infants will save lives. 

“This is an opportunity to prevent hospitalisation of babies and saves lives,” she said.

“Other states have taken action here, either making immunisations available to all new babies or through more targeted efforts.

“RSV is a serious disease that puts children in hospital every year. People may not realise the enormous health burden it places on children five and under in Australia. Not only is it likely the number one cause of hospitalisation among young children, up to a quarter of them need intensive care treatment. That’s an absolute nightmare for a young family to go through.

“With an immunisation program to match the one in Western Australia, we can keep children out of hospital beds, save families from a terrible experience, and be proactive about public health to relieve pressure on our health system, including our already under-pressure hospitals.”

~ENDS


About us:

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here.


Contact details:

John Ronan
Media Adviser

Ally Francis
Media Adviser

Stuart Winthrope
Media Officer

Contact: 03 8699 0992media@racgp.org.au

Follow us on Twitter: @RACGP and Facebook.

Media

More from this category

  • Medical Health Aged Care
  • 04/10/2024
  • 06:00
Monash University

New drug could be answer to an overlooked yet devastating type of dementia

Monash University researchers are assessing a new drug that could be a game changer for the dementia that has struck US actor Bruce Willis, and countless others as young as 35: behavioural variant frontotemporal dementia (bvFTD). Unlike other types of dementia, such as Alzheimer’s Disease, there are no treatments; but a new drug — sodium selenate — was shown to be safe and well tolerated in people living with bvFTD, as outlined in the team’s 2022 study. Now,the team is announcing the next step: measuring the drug’s impact on brain functioning. While relatively rare, FTD causes progressive damage and shrinkage…

  • Medical Health Aged Care
  • 04/10/2024
  • 01:26
Dark Horse Consulting Group

Dark Horse Consulting Group Acquires BioTechLogic, Inc.

Combined organization to offer strategic advisory, operations, and technical consulting across the biopharma industryWALNUT CREEK, Calif. and CAVE CREEK, Ariz. and BOSTON, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Dark Horse Consulting Group (“DHC”), the longstanding global leader in strategic and operational consulting in the field of cell and gene therapy (“CGT”), is delighted to announce the acquisition of BioTechLogic, Inc. (“BioTechLogic”), a recognized forerunner in technical operations, manufacturing, quality, and regulatory CMC consulting. This strategic acquisition marks a significant milestone in DHC’s growth, combining the complementary strengths of both teams while further consolidating DHC’s position at the vanguard of CGT.DHC—with…

  • Medical Health Aged Care
  • 03/10/2024
  • 18:26
Ferring Pharmaceuticals

Ferring Pharmaceuticals bolsters global gene therapy supply chain with European manufacturing facility

This milestone represents significant progress in Ferring’s manufacturing capabilities to meet anticipated growth in demand for Adstiladrin® (nadofaragene firadenovec-vncg), a gene therapy for people…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.